Frank Beurskens

Frank Beurskens has extensive experience in antibody research and technology, currently serving as the Director and Antibody Format Translation Lead at Genmab since September 2002. Earlier roles at Genmab include Associate Director and Principal Scientist, focusing on the development of new antibody formats into potential immuno-therapeutics. Prior to Genmab, Frank worked as a Post-doctoral fellow at Brigham and Women's Hospital, investigating the complement system's role in inflammation. Frank completed a PhD on the complement system related to systemic lupus erythematosus at UMC Utrecht, where earlier positions included Junior Scientist focusing on the innate immune system of pre-mature neonates. Educational qualifications include an Ms in Biology from Utrecht University and earlier studies at Collegium Marianum Venlo.